Griffin Asset Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Hold
30,699
0.18% 108
2025
Q4
$1.57M Buy
30,699
+564
+2% +$26.1K 0.17% 109
2025
Q3
$1.17M Hold
30,135
0.13% 123
2025
Q2
$906K Hold
30,135
0.11% 135
2025
Q1
$859K Hold
30,135
0.11% 129
2024
Q4
$995K Hold
30,135
0.12% 131
2024
Q3
$1.12M Buy
30,135
+7,170
+31% +$261K 0.13% 131
2024
Q2
$771K Buy
22,965
+15,000
+188% +$503K 0.09% 147
2024
Q1
$285K Hold
7,965
0.03% 192
2023
Q4
$262K Buy
+7,965
New +$214K 0.03% 193
2022
Q3
Sell
-9,120
Closed -$253K 213
2022
Q2
$253K Hold
9,120
0.04% 192
2022
Q1
$307K Hold
9,120
0.04% 192
2021
Q4
$385K Hold
9,120
0.05% 183
2021
Q3
$415K Hold
9,120
0.05% 184
2021
Q2
$446K Hold
9,120
0.05% 193
2021
Q1
$458K Hold
9,120
0.06% 179
2020
Q4
$467K Hold
9,120
0.06% 164
2020
Q3
$375K Hold
9,120
0.06% 164
2020
Q2
$381K Hold
9,120
0.06% 165
2020
Q1
$289K Hold
9,120
0.05% 168
2019
Q4
$386K Hold
9,120
0.05% 169
2019
Q3
$288K Sell
9,120
-1,638
-15% -$57.6K 0.04% 187
2019
Q2
$389K Hold
10,758
0.05% 189
2019
Q1
$389K Hold
10,758
0.06% 189
2018
Q4
$303K Buy
+10,758
New +$357K 0.05% 191

Other funds holding SBIO

Griffin Asset Management's SBIO Position: Q1 2026 in Review

Griffin Asset Management held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q1 2026 at 30,699 shares worth $1.61M. The position accounts for 0.18% of the portfolio, ranked #108.

Griffin Asset Management first reported a position in SBIO in Q4 2018 and has held it in 25 quarters since. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Griffin Asset Management held 30,699 shares of ALPS Medical Breakthroughs ETF worth $1.61M as of Q1 2026.
  • Griffin Asset Management left its ALPS Medical Breakthroughs ETF share count unchanged in Q1 2026.
  • ALPS Medical Breakthroughs ETF made up 0.18% of Griffin Asset Management's portfolio in Q1 2026, its #108 holding.
  • Griffin Asset Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2018 and has held it in 25 quarters since.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Griffin Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.